Sensorion SA (EPA:ALSEN)
France · Delayed Price · Currency is EUR 0.2750
-0.0090 (-3.17%)
Aug 3, 2026, 1:44 PM CET
Sensorion Market Cap
Sensorion has a market cap or net worth of €146.18 million as of August 3, 2026. Its market cap has increased by 40.60% in one year.
Market Cap
146.18M
Enterprise Value
99.96M
Revenue
5.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.28
ChartMarket Cap Chart
Since April 21, 2015, Sensorion's market cap has increased from 20.46M to 146.18M, an increase of 614.60%. That is a compound annual growth rate of 19.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 146.18M | 44.37% |
| Dec 31, 2025 | 101.25M | -47.00% |
| Dec 31, 2024 | 191.03M | 137.65% |
| Dec 29, 2023 | 80.38M | 171.97% |
| Dec 30, 2022 | 29.56M | -80.74% |
| Dec 31, 2021 | 153.45M | 33.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 407.36M |
| Valerio Therapeutics Société anonyme | 370.09M |
| Transgene | 194.73M |
| Cellectis | 179.18M |
| Innate Pharma | 143.70M |
| Adocia | 77.48M |
| OSE Immunotherapeutics | 75.41M |
| ABIONYX Pharma | 65.50M |